Bioventus Acquires U.S. Distribution Rights to GELSYN-3 HA Injection
Bioventus entered into a multi-year agreement with Institut Biochimique, gaining exclusive U.S. distribution rights for GELSYN-3™ 3-injection hyaluronic acid product for pain relief...